Curaleaf Holdings (CURLF) Operating Leases (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Operating Leases of $102.3 million for Q4 2025, down 3.62% year-on-year from $106.2 million in Q4 2024, and down 3.62% on a QoQ basis from $106.2 million in Q4 2024.
Curaleaf Holdings (CURLF) Operating Leases (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Operating Leases for 7 consecutive years, with $102.3 million the latest figure, recorded in Q4 2025.
- Quarterly Operating Leases fell 3.62% year-over-year to $102.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $102.3 million (down 3.62% YoY) and the FY2025 annual result came in at $102.3 million, down 3.62% from the prior year.
- Operating Leases slipped to $102.3 million in Q4 2025 per CURLF's latest filing, from $106.2 million in the prior quarter.
- Over the last five years, Operating Leases for CURLF reached as high as $322.0 billion in Q1 2022 and fell as low as $65.5 million in Q4 2021.
- A 5-year average of $21.6 billion and a median of $112.6 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases slumped 75.79% — and 2022, when it jumped 118732.03%.
- Year by year, Operating Leases stood at $65.5 million in 2021, then surged by 72.99% to $113.3 million in 2022, then fell by 2.57% to $110.4 million in 2023, then declined by 3.81% to $106.2 million in 2024, then dropped by 3.62% to $102.3 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $102.3 million, $106.2 million, and $108.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 102.35 Mn |
| Dec 31, 2024 | 106.19 Mn |
| Sep 30, 2024 | 108.71 Mn |
| Jun 30, 2024 | 109.85 Mn |
| Dec 31, 2023 | 110.40 Mn |
| Sep 30, 2023 | 109.50 Mn |
| Jun 30, 2023 | 112.57 Mn |
| Dec 31, 2022 | 113.31 Mn |
| Sep 30, 2022 | 400.40 Mn |
| Jun 30, 2022 | 378.58 Mn |
| Mar 31, 2022 | 321.97 Bn |
| Dec 31, 2021 | 65.50 Mn |
| Sep 30, 2021 | 291.33 Mn |
| Jun 30, 2021 | 293.19 Mn |
| Mar 31, 2021 | 270.95 Mn |
| Dec 31, 2020 | 270.50 Mn |
| Sep 30, 2020 | 259.22 Mn |
| Dec 31, 2019 | 81.32 Mn |